Xiao Ping Jin
Technik-/Wissenschafts-/F&E-Leiter bei SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
Profil
Xiao Ping Jin is currently the Chief Medical Officer & Deputy General Manager at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Prior to this, he worked as a Scientific Director at AstraZeneca PLC and NASDAQ OMX Group, Inc. from 2014 to 2017.
He also served as the Vice President at Akeso, Inc. from 2020 to 2021.
Dr. Jin received his undergraduate degree from Nanjing University in 1997, his graduate degree from Washington State University in 2001, and his doctorate from the University of Minnesota School of Public Health in 2005.
Aktive Positionen von Xiao Ping Jin
| Unternehmen | Position | Beginn |
|---|---|---|
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Technik-/Wissenschafts-/F&E-Leiter | 06.09.2021 |
Ehemalige bekannte Positionen von Xiao Ping Jin
| Unternehmen | Position | Ende |
|---|---|---|
| AKESO, INC. | Corporate Officer/Principal | 01.08.2021 |
| ASTRAZENECA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2017 |
NASDAQ OMX Group, Inc.
 NASDAQ OMX Group, Inc. Financial ConglomeratesFinance NASDAQ OMX Group, Inc. provides investment services. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2017 |
Ausbildung von Xiao Ping Jin
| Nanjing University | Undergraduate Degree |
| Washington State University | Graduate Degree |
| University of Minnesota School of Public Health | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AKESO, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
NASDAQ OMX Group, Inc.
NASDAQ OMX Group, Inc. Financial ConglomeratesFinance NASDAQ OMX Group, Inc. provides investment services. | Finance |
